Pearls from the ashes
By Deval (Reshma) Paranjpe, MD, MBA, FACS The siege has lasted one year now. One year since the pandemic caused our lives to change in ways we’d never imagined. One year since everything shut down and all manner of unthinkable things ensued. One year since we started to see both the best and the worst […]
The most important test no one remembers
Newborn screening (NBS) has been cited by the U.S. Center for Disease Control (CDC) as one of the most impactful public health initiatives of the 20th century, and in the 21st century has undergone significant expansion through improved techniques of high throughput biochemical analysis, enzymatic activities and specific molecular defects. Screening is particularly indicated for […]
Unmasking appreciation
Dr. Andrea Taylor-Cummings said, “People go where they feel welcome, but stay where they feel valued.” Not all attempts to show appreciation are equal, especially through the eyes of the recipient. A recent online search for “how to show appreciation” led me to YouTube, where a millennial couple talked about how they’ve never felt more […]
One year later
I’ve been the business manager for Weinstein Imaging Associates for 40-plus years. During that time, I’ve seen major changes in technology, healthcare policies/practices, insurances (introduction of HMOs!), not to mention fashion, music and hairstyles. You would think the saying “I’ve just about seen it all” would apply. Sadly, the early months of 2020 and the […]
Meet Your 2021 ACMS President: Patricia L. Bononi, MD, FACP
Patricia L. Bononi, MD, FACP Patricia L. Bononi, MD, FACP, has been named 2021 ACMS president, becoming the 155th president and the fifth woman to hold that position. A native of Greensburg, Dr. Bononi knew at an early age that she wanted to be a physician, and found inspiration from her mother, a registered […]
DNA Database Risks to Privacy and Safety
It was only a matter of time. The recent announcement that GlaxoSmithKline bought a $300 million dollar stake in the leading genomics company 23andMe and now has exclusive rights to 23andMe’s DNA data for drug testing research should come as no surprise to those of you who have been watching the intersection of technology companies […]